Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

UK's first cross sector International Dementia Conference to take place in November 2015

Taking place 3 - 4 November 2015 at Vox Birmingham, the UK's first cross sector International Dementia Conference will bring together leading figures from across the world and from a variety of different industry backgrounds to learn and share ideas on the best solutions to tackle this global issue.

7 Aug 2015

Johns Hopkins researchers discover role of TDP-43 protein in autopsy brain cells of patients with ALS

Autopsies of nearly every patient with the lethal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), and many with frontotemporal dementia (FTD), show pathologists telltale clumps of a protein called TDP-43. Now, working with mouse and human cells, Johns Hopkins researchers report they have discovered the normal role of TDP-43 in cells and why its abnormal accumulation may cause disease.

7 Aug 2015

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

Boston Medical Center has received a $1.3 million grant from the Agency for Healthcare Research and Quality to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose death in two New England States: Massachusetts and Rhode Island.

7 Aug 2015

Early cognitive changes linked to white matter damage in Parkinson’s

Subtle changes in white matter integrity are detectable in patients with Parkinson’s disease and are associated with early impairments in cognition, say researchers.

6 Aug 2015

Modern living could lead to 'hidden' epidemic of neurological brain disease

Modern living could be responsible for an 'almost epidemic' increase in neurological brain disease, according to new research from Bournemouth University.

6 Aug 2015

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.

6 Aug 2015

Sleeping in lateral position may effectively remove brain waste, say Stony Brook researchers

Sleeping in the lateral, or side position, as compared to sleeping on one's back or stomach, may more effectively remove brain waste and prove to be an important practice to help reduce the chances of developing Alzheimer's, Parkinson's and other neurological diseases, according to researchers at Stony Brook University.

5 Aug 2015

Aging adults who follow MIND diet can delay cognitive decline

While cognitive abilities naturally diminish as part of the normal aging process, it may be possible to take a bite out of this expected decline.

5 Aug 2015

Study reports significant decline in new cases of Alzheimer disease, other dementias in African-Americans

An Indiana University and Regenstrief Institute study is the first to report significantly decreased incidence rates over two decades for Alzheimer's disease and other dementias in African-Americans. The study is also the first to show that the incidence rate of these conditions in Africans was unchanged over the same period.

5 Aug 2015

Researchers reveal how insulin reaches and acts in the brain to improve memory

Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.

5 Aug 2015

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix Corp. is pleased to announce the formation of an international Clinical Steering Committee for the RVX-208 "apabetalone" Phase 3 clinical trial BETonMACE assessing major adverse cardiac events (MACE) in high-risk vascular patients with diabetes mellitus and a recent Acute Coronary Syndrome event. BETonMACE is expected to start in the fall of 2015.

4 Aug 2015

Dementia patients, caregivers think better care, support more important than finding cure for disease

More than $100 million in federal funding was spent last year toward searching for a cure for Alzheimer's disease. However, if given the choice, most people with dementia and those caring for them would like to see the money go elsewhere, according to a recent study led by University at Buffalo researcher Davina Porock.

4 Aug 2015

BrightFocus announces recipients of 2015 research program grants

BrightFocus Foundation, which funds research worldwide on Alzheimer's disease, glaucoma, and macular degeneration, today announced that its 2015 research program grants have been awarded to 58 scientists in 20 states and 7 foreign countries. Part of an $11 million research investment, the grants reflect the largest annual research funding in the foundation's history.

4 Aug 2015

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Scientists at The New York Stem Cell Foundation Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells.

4 Aug 2015

15th Annual Geriatric Health Care Symposium now open for registration

Registration is now open for the 15th Annual Geriatric Health Care Symposium, "Maximizing Independence for Optimal Aging," presented by the University of Louisville Institute for Sustainable Health & Optimal Aging.

3 Aug 2015

Anti-dementia drugs could result in harmful weight loss, say researchers

Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, they said.

3 Aug 2015

Researchers closer to understanding complicated brain chemistry behind Alzheimer's disease

Researchers at the University of Melbourne have discovered that a protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health.

3 Aug 2015

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

31 Jul 2015

Female patients with depression have abnormally high expression levels of glutamate receptor genes

Numerous genes that regulate the activity of a neurotransmitter in the brain have been found to be abundant in brain tissue of depressed females. This could be an underlying cause of the higher incidence of suicide among women, according to research at the University of Illinois at Chicago.

31 Jul 2015

Study reveals new way to help medical students learn about Alzheimer's disease

With the growing number of people with Alzheimer's disease, understanding their care is vital for doctors. Yet medical students often just learn the facts and may only see people with advanced disease who are at the hospital or nursing home. A study shows a new way to help medical students learn about the disease—at the art museum.

30 Jul 2015

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

UK's first cross sector International Dementia Conference to take place in November 2015

Johns Hopkins researchers discover role of TDP-43 protein in autopsy brain cells of patients with ALS

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

Early cognitive changes linked to white matter damage in Parkinson’s

Modern living could lead to 'hidden' epidemic of neurological brain disease

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Sleeping in lateral position may effectively remove brain waste, say Stony Brook researchers

Aging adults who follow MIND diet can delay cognitive decline

Study reports significant decline in new cases of Alzheimer disease, other dementias in African-Americans

Researchers reveal how insulin reaches and acts in the brain to improve memory

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Dementia patients, caregivers think better care, support more important than finding cure for disease

BrightFocus announces recipients of 2015 research program grants

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

15th Annual Geriatric Health Care Symposium now open for registration

Anti-dementia drugs could result in harmful weight loss, say researchers

Researchers closer to understanding complicated brain chemistry behind Alzheimer's disease

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Female patients with depression have abnormally high expression levels of glutamate receptor genes

Study reveals new way to help medical students learn about Alzheimer's disease

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in